|
Schlusskurs
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 59.80 TWD | -1.81% |
|
-2.61% | -2.29% |
Hauptkonkurrenten
| Dividendenrendite (Y) | Dividendenrendite (Y+1) | KGV (Y) | Price to Book (Y) | EV / Sales (Y) | Marktkap. / EBITDA (Y) | Marktkap. / EBIT (Y) | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | -105x | 4.24x | 27.6x | -312.31x | -100.99x | 527 Mio. | ||
| 0.02% | 0.04% | 44.76x | 7.08x | 10.62x | 38.01x | 39.26x | 47.98 Mrd. | ||
| 1.64% | 1.5% | 17.74x | 4.25x | 6.36x | 13.98x | 15.5x | 43.84 Mrd. | ||
| -.--% | -.--% | -27.29x | 91.84x | 59.81x | -30.05x | -28.97x | 34.43 Mrd. | ||
| -.--% | -.--% | -27.62x | 1.26x | 4.82x | -13.15x | -10.4x | 27.35 Mrd. | ||
| -.--% | -.--% | 31.31x | 2.9x | 6.18x | 17.12x | 21.31x | 20.07 Mrd. | ||
| -.--% | -.--% | 17.27x | 3.33x | 4.37x | 11.58x | 12.33x | 19.62 Mrd. | ||
| -.--% | -.--% | -407.05x | 12.72x | 27.88x | 658.11x | -446.74x | 13.86 Mrd. | ||
| -.--% | -.--% | -194.83x | 23.88x | 46.29x | -187.55x | -166.08x | 13.4 Mrd. | ||
| -.--% | -.--% | -13.14x | - | 165.06x | -25.74x | -12.88x | 13.14 Mrd. | ||
| -.--% | -.--% | 16.81x | 4.53x | 4.84x | 11.88x | 13.18x | 11.83 Mrd. | ||
| -.--% | -.--% | -46.98x | 18.88x | 11.44x | -44.64x | -42.24x | 11.39 Mrd. | ||
| -.--% | -.--% | -18.12x | 16.04x | 20.07x | -25.42x | -18.25x | 8.77 Mrd. | ||
| -.--% | -.--% | -18.22x | 7.85x | - | -18.73x | -18.09x | 8.1 Mrd. | ||
| -.--% | -.--% | -169.55x | 20.63x | 19.02x | 582.93x | -166.65x | 7.8 Mrd. | ||
| -.--% | -.--% | -9.84x | -13.63x | 89.24x | -12.02x | -11.78x | 7.65 Mrd. | ||
| Durchschnitt | 0.11% | 0.1% | -56.86x | 13.72x | 33.57x | 41.50x | -57.59x | 18.11 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 0.25% | 0.23% | -28.72x | 17.62x | 26.89x | 39.45x | -30.06x |
- Börse
- Aktien
- 4147 Aktie
- Sektor TaiMed Biologics Inc.
- branchenspezifische Dividenden
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben
















